目的 探讨长链非编码RNA LINC00963通过调控TLR4/MyD88/NF-κB信号通路减轻脓毒症心肌损伤(SIMD)的作用机制。方法 采用盲肠结扎穿孔术(CLP)建立脓毒症小鼠模型(n=24),随机分为LINC00963过表达慢病毒组(LV-LINC00963-OE组)、敲低组(LV-LINC00963-KD组)及相应阴性对照组。通过慢病毒载体转染RAW264.7巨噬细胞,经尾静脉注射调控LINC00963表达,术后7 d取心脏组织行HE染色评估病理损伤程度;采用Western blot检测TNF-α、NF-κB p65、MyD88及AP-1蛋白表达。结果 LINC00963敲低组心肌间质水肿评分显著高于对照组[(3.8±0.4) vs. (1.2±0.3)],P<0.01,且促炎因子TNF-α、NF-κB p65、MyD88及AP-1表达上调1.7~2.5倍,差异有统计学意义(P<0.01);在LINC00963过表达组中,上述指标显著降低,差异有统计学意义(P<0.01)。结论 LINC00963通过靶向抑制TLR4/MyD88/NF-κB信号通路介导的炎症反应,减轻脓毒症心肌损伤,为临床干预脓毒症心肌病提供了潜在治疗靶点。
Abstract
Objective To explore the mechanism of long non-coding RNA LINC00963 in alleviating myocardial injury in sepsis through regulating the TLR4/MyD88/NF-κB signaling pathway. Methods A murine sepsis model was established by cecal ligation and puncture (CLP) (n=24). Mice were randomly divided into a LINC00963 overexpression lentivirus group (LV-LINC00963-OE), a LINC00963 knockdown lentivirus group (LV-LINC00963-KD), and a corresponding negative control group. RAW264.7 macrophages were transfected with lentiviral vectors, and the LINC00963 expression was regulated by tail vein injection. Cardiac tissues were harvested 7 days after surgery for HE staining to evaluate the degree of pathological injury; Western blot was used to detect the expression of TNF-α, NF-κB p65, MyD88, and AP-1 proteins. Results The myocardial interstitial edema score in the LV-LINC00963-KD group was significantly higher than that in the control group [(3.8±0.4) vs. (1.2±0.3), P<0.01], and the expression of pro-inflammatory factors TNF-α, NF-κB p65, MyD88, and AP-1 was upregulated by 1.8 to 2.5 times, with statistically significant differences (P<0.01). Conversely, in the LV-LINC00963-OE group, the above indicators were significantly reduced , with statistically significant differences (P<0.01). Conclusions LINC00963 mediates the inflammatory response by targeting the TLR4/MyD88/NF-κB signaling pathway, alleviating myocardial injury in sepsis, providing a potential therapeutic target for clinical intervention of septic cardiomyopathy.
关键词
脓毒症心肌病 /
LINC00963 /
促炎细胞因子 /
TLR4/MyD88/NF-κB通路 /
细胞凋亡
Key words
septic cardiomyopathy /
LINC00963 /
pro-inflammatory cytokines /
TLR4/MyD88/NF-κB signaling pathway /
apoptosis
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Singer M, Deutschman C S, Seymour C W, et al. The third international consensus definitions for sepsis and septic shock(Sepsis-3)[J]. JAMA, 2016, 315(8):801-810.
[2] Wang X, Liu Q, Zhu H, et al. Mitochondrial dysfunction in septic cardiomyopathy: mechanisms and therapeutic strategies[J]. J Mol Cell Cardiol, 2021, 154:34-45.
[3] 张 涛,刘红梅,陈志强,等. 长链非编码RNA LINC00963在脓毒症心肌损伤患者血清中的表达及临床意义[J].中华危重病急救医学, 2023, 35(7): 721-726.
[4] Chen L L, Zhao Y, Wang M, et al. Emerging roles of long non-coding RNAs in sepsis-induced organ injury[J]. Front Immunol, 2022, 13:903812.
[5] Rittirsch D, Huber-Lang M S, Flierl M A, et al. Immunodesign of experimental sepsis by cecal ligation and puncture[J]. Nat Protoc,2009,4(1):31-36.
[6] Suzuki K, Ota H, Sasagawa S, et al. Assay method for myeloperoxidase in human polymorphonuclear leukocytes[J]. Anal Biochem,1983,132(2):345-352.
[7] Zhang H, Li Y, Wang J, et al. LncRNA MALAT1 attenuates sepsis-induced myocardial injury via miR-150-5p/PDCD4 axis[J]. Shock, 2022, 57(2):267-275.
[8] Wang Y, Chen L, Zhang Q, et al. LINC00963 exacerbates TNF-α-mediated mitochondrial dysfunction in septic cardiomyopathy[J]. J Mol Cell Biol, 2023, 15(2):123-135.
[9] Fu Y J, Zhang K, Liu H, et al. TLR4/MyD88/NF-κB signaling in sepsis-induced cardiomyopathy[J]. J Am Heart Assoc, 2020, 9(9):e016551.
[10] 王建军, 李 伟, 张 涛, 等. 脓毒症心肌损伤中TLR4信号通路的调控机制[J]. 武警医学, 2021, 32(5):401-405.
[11] Zhang H, Wu T, Li X, et al. LncRNA MALT4 inhibits TLR4/NF-κB signaling by sponging miR-155-5p in septic myocardial injury[J]. Nat Commun, 2023, 14:5123.
[12] Wang L, Zhao M, Chen X, et al. LncRNA HOTAIR exacerbates myocardial inflammation via the TLR4/MyD88/NF-κB axis in sepsis[J]. Circ Res, 2023, 133(1):45-58.
[13] Tan S, Chen Z, Liu Y, et al. LncRNA-mediated epigenetic silencing of NF-κB inhibitors exacerbates septic cardiomyopathy[J]. Circ Res, 2023, 132(5):45-60.
[14] Li R, Wang J, Zhang L, et al. LncRNA H19 suppresses JNK/AP-1 signaling to alleviate myocardial ischemia-reperfusion injury[J]. Cardiovasc Res, 2021, 117(12):2457-2470.
[15] 陈 立, 吴 芳, 郑 伟, 等. LncRNA HOTAIR通过miR-146a/TRAF6轴调控巨噬细胞炎症反应加重脓毒症心肌损伤的机制[J]. 中国病理生理杂志, 2022, 38(11): 1985-1992.
[16] Liu Y, Zhang M, Wang S, et al. LncRNA NEAT1 regulates NLRP3 inflammasome activation via MyD88 ubiquitination in septic cardiomyopathy[J]. J Mol Cell Cardiol, 2023, 174:45-58.
[17] Wang J, Xu H, Li F, et al. AP-1 as a dual regulator of inflammation and fibrosis in cardiovascular diseases[J]. Pharmacol Ther, 2022, 233:108025.
[18] Luo Y, Wang X, Chen J, et al. LncRNA NEAT1 promotes NLRP3 inflammasome activation via m6A modification in septic cardiomyopathy[J]. Nat Commun, 2023, 14:4321-4331.
[19] Chen Z, Li H, Wu Y, et al. LncRNA MEG3 suppresses NLRP3 inflammasome via HDAC2-dependent chromatin remodeling in sepsis[J]. Circ Res, 2023, 132:987-1002.
[20] Li R, Zhang H, Chen M, et al. LncRNA H19 attenuates cardiac fibrosis by targeting the JNK/AP-1 pathway in sepsis[J]. Nat Commun, 2023, 14:6890-6899.
[21] Liu Y, Zhao X, Zhang W, et al. LncRNA Kcnq1ot1 modulates macrophage polarization via miR-214-3p/DUSP1 axis in septic cardiomyopathy[J]. Nat Commun, 2023, 14:4321-4325.
[22] Zhou M T, Zhang Q, Li S, et al. Targeting AP-1/NF-κB heterodimerization: a novel anti-inflammatory strategy in septic cardiomyopathy[J]. J Clin Invest, 2024, 134(3):e178921.
[23] Andersson U, Ottosson L, Palmblad K, et al. Extracellular HMGB1 amplifies macrophage-cardiomyocyte crosstalk in sepsis via RAGE/TLR4[J]. Intensive Care Med, 2023, 49(11):1293-1305.
[24] Zhang Y, Wang L, Chen H, et al. LncRNA TUG1 coordinates NF-κB and Nrf2 pathways to mitigate oxidative stress in sepsis[J]. Circ Res, 2023, 132:145-160.
[25] Tan S, Liu F, Wang H, et al. LncRNA-mediated DNA methylation suppresses PPARγ signaling in septic myocardial injury[J]. Nat Commun, 2023, 14:8902-8906.